Dan Ives, Wedbush Securities global head of technology research, joins CNBC's 'Squawk on the Street' to discuss outlooks on ...

Fintel reports that on March 12, 2025, Wedbush downgraded their outlook for Arvinas (NasdaqGS:ARVN) from Outperform to ...

Various factors have weighed on tech stocks this year, including investor unease over Trump's tariffs and AI spending.

Telos (NASDAQ:TLS – Get Free Report)‘s stock had its “outperform” rating reissued by Wedbush in a research note issued on Tuesday,Benzinga reports. They presently have a $6.00 target price on the ...

Despite the recent sell-off in tech stocks, analysts at Wedbush believe that this downturn is temporary and that AI leaders ...

Wedbush analyst Laura Chico maintained a Buy rating on Astria Therapeutics (ATXS – Research Report) today and set a price target of $28.00. The ...

Market fears over tariffs and growth have hit tech stocks, but Wedbush sees the dip as a buying opportunity for long-term investors ...

With Elon Musk playing a prominent role in the Trump administration, many Tesla drivers are no longer happy about supporting ...

Immunome (NASDAQ:IMNM – Get Free Report)‘s stock had its “outperform” rating reiterated by analysts at Wedbush in a research ...

Tesla stock is gaining ground on the heels of two significant news items today. President Trump made a statement of support for the company and its CEO, Elon Musk, and Wedbush put out analysis ...

Shares of Tesla slid again Monday as confidence in Elon Musk’s electric car company continues to disintegrate following a ...

Elon Musk’s role in the Trump administration is complicating his business ventures, as the tech billionaire pushes forward with efforts to slash the federal government and budget in the face of ...